MAPLE GROVE, Minn., June 9, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced that it is the recipient of a Distribution Industry Award for Notable Achievements in Healthcare (DIANA) given by the Healthcare Distribution Management Association (HDMA). The Company was presented with one of the two "2014 DIANA Manufacturer Partner of the Year" awards. The Company was also recognized as a Merit Finalist for the "Best Overall Branded Pharmaceutical Product Manufacturer with Sales to Healthcare Distributors of Less Than $300 Million." The HDMA recognized leading pharmaceutical and consumer product manufacturers with the presentation of 10 DIANA Awards at its 2014 Business and Leadership Conference in Phoenix, Arizona on June 2, 2014.
For more than 50 years, the DIANA Awards have been presented to healthcare and consumer product manufacturers that set the standard for excellence in new product introductions and promotions. DIANA winners are chosen by HDMA distributor members who judge companies based on several criteria including: knowledgeable salespeople, high-level customer service, demonstrated flexibility and creativity in marketing, and incorporation of new technologies to ensure product safety and security. Upsher-Smith is included among a distinguished group of past recipients who serve as models for leadership and innovation in the healthcare marketplace.
"We are honored to be one of the select companies recognized by HDMA members for this prestigious DIANA Award," said Scott Hussey, Sr. Vice President, Sales, Upsher-Smith Laboratories, Inc. "At Upsher-Smith we strive to be an outcomes-driven partner in healthcare and to deliver high-quality, high-value products to patients. We would like to thank the HDMA members for their recognition, and for naming Upsher-Smith Partner of the Year."
Upsher-Smith Laboratories, Inc., founded in 1919, is a growing pharmaceutical company dedicated to its mission of Advancing Pharmacotherapy. Improving Life™. With capabilities ranging from early-stage research to delivering on-market products, Upsher-Smith is committed to offering quality products that enable people to live life to its greatest potential. Upsher-Smith's approach to product development and partnering has resulted in a broad range of both branded and generic therapeutic solutions to address patients' needs. The Company has a particular focus on developing therapies for people living with central nervous system (CNS) conditions, such as seizure disorders, and has a robust pipeline of promising CNS compounds in various stages of development. For more information, visit www.upsher-smith.com.
HDMA is the national association representing primary healthcare distributors, the vital link between the nation's pharmaceutical manufacturers and healthcare providers. Each business day, HDMA member companies ensure that 15 million prescription medicines and healthcare products are delivered safely and efficiently to nearly 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation's healthcare system.
SOURCE Upsher-Smith Laboratories, Inc.